甘/胃腸藥顆粒

Pays: Taïwan

Langue: chinois

Source: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

Ingrédients actifs:

HYDROTALCITE;;SODIUM BICARBONATE ( EQ TO SODIUM HYDROGEN CARBONATE);;DIASTASE BIO-;;ZEDOARY;;CINNAMON POWDER (CINNAMON CORTEX POWDER);;SCOPOLIA EXTRACT POWDER;;FENNEL POWDER (FOENICULI POWDER);;CLOVE POWDER;;L-MENTHOL ;;GLYCYRRHIZA (LIQUORICE)

Disponible depuis:

林璋貿易有限公司 台北市中山區四平街14號1樓 (97316413)

Code ATC:

A02X

forme pharmaceutique:

內服顆粒劑

Composition:

SCOPOLIA EXTRACT POWDER (1208004503) 100.000MG; SODIUM BICARBONATE ( EQ TO SODIUM HYDROGEN CARBONATE) (4008000700) 400.000MG; HYDROTALCITE (5604002000) (SYN.) 233.333MG; CINNAMON POWDER (CINNAMON CORTEX POWDER) (5610000103) 66.667MG; FENNEL POWDER (FOENICULI POWDER) (5610000301) 40.000MG; DIASTASE BIO- (5616000780) 100.000MG; ZEDOARY (5616004900) (POWDER) 120.000MG; CLOVE POWDER (7200000301) 10.000MG; L-MENTHOL (8408000302) 2.000MG; GLYCYRRHIZA (LIQUORICE) (9200004400) (POWDER) 33.333MG

Unités en paquet:

盒裝;;罐裝

classe:

製　劑

Type d'ordonnance:

須經醫師指示使用

Fabriqué par:

TOHO PHARMACEUTICAL CO. LTD. 214-1, AZA-KUBO KASHIHARA-CITY, NARA-PREF., 634-0073 JAPAN JP

Domaine thérapeutique:

OTHER DRUGS FOR ACID RELATED DISORDERS

indications thérapeutiques:

胃酸過多、胃部膨滿感、胃痛、消化不良、消化不良引起的胃腹部膨滿感

Descriptif du produit:

註銷日期: 2019/03/28; 註銷理由: 未展延而逾期者; 有效日期: 2018/05/26; 英文品名: AMAGASHI ICHOYAKU-E CRANULE

Statut de autorisation:

已註銷

Date de l'autorisation:

1988-07-25